Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its first quarter ended March 31, 2020 , after the market close on May 6, 2020 . Natera will host a conference call and webcast at 1:30 p.m. PT ( 4:30 p.m. ET ) to discuss its financial resu
| SAN CARLOS, Calif., April 29, 2020 /PRNewswire/ --Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its first quarter ended March 31, 2020, after the market close on May 6, 2020. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.
A webcast replay will be available at investor.natera.com. About Natera Natera is a global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on reproductive health, oncology, and organ transplantation. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. It offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn. Contacts
SOURCE Natera, Inc. | ||||||||||||||||||||||||||||||
Company Codes: NASDAQ-NMS:NTRA | ||||||||||||||||||||||||||||||
View original content to download multimedia:
